ES2091159B1 - Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion. - Google Patents

Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.

Info

Publication number
ES2091159B1
ES2091159B1 ES09401198A ES9401198A ES2091159B1 ES 2091159 B1 ES2091159 B1 ES 2091159B1 ES 09401198 A ES09401198 A ES 09401198A ES 9401198 A ES9401198 A ES 9401198A ES 2091159 B1 ES2091159 B1 ES 2091159B1
Authority
ES
Spain
Prior art keywords
rsm14
recombinant antigen
coming
obtaining
mansoni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09401198A
Other languages
English (en)
Other versions
ES2091159A1 (es
Inventor
Miriam Tendler
Naftale Katz
Andrew John Simpson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oswaldo Cruz Foundation
Original Assignee
Oswaldo Cruz Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oswaldo Cruz Foundation filed Critical Oswaldo Cruz Foundation
Publication of ES2091159A1 publication Critical patent/ES2091159A1/es
Application granted granted Critical
Publication of ES2091159B1 publication Critical patent/ES2091159B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ANTIGENO RECOMBINANTE, RSM14, PROCEDENTE DE CVASCHISTOSOMA MANSONI, SU OBTENCION Y UTILIZACION. EL ANTIGENO RECOMBINANTE RSM14 ES UNA PROTEINA DE FUSION QUE COMPRENDE UNA CADENA POLIPEPTIDICA DERIVADA DE UN BACTERIOFAGO UNIDA A LA CADENA POLIPEPTIDICA DE LA PROTEINA SM14 NATIVA DE CVASCHISTOSOMA MANSONI POR UN ENLACE PEPTIDICO. EL ANTIGENO PUEDE OBTENERSE POR EXPRESION DE UN MICROORGANISMO TRANSFORMADO Y PUEDE SER UTILIZADO COMO VACUNA CONTRA LAS ENFERMEDADES CAUSADAS POR LAS INFECCIONES HELMINTICAS DE HUMANOS Y ANIMALES, EN PARTICULAR, LAS CAUSADAS POR ESPECIES DE CVASCHISTOSOMA O FASCIOLA, ASI COMO REACTIVO PARA LA DIAGNOSIS DE ESQUISTOSOMIASIS Y FASCIOLIASIS.
ES09401198A 1993-12-16 1994-06-01 Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion. Expired - Fee Related ES2091159B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9305075A BR9305075A (pt) 1993-12-16 1993-12-16 Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico

Publications (2)

Publication Number Publication Date
ES2091159A1 ES2091159A1 (es) 1996-10-16
ES2091159B1 true ES2091159B1 (es) 1997-05-01

Family

ID=39496068

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09401198A Expired - Fee Related ES2091159B1 (es) 1993-12-16 1994-06-01 Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.

Country Status (10)

Country Link
US (1) US5730984A (es)
JP (1) JP4087908B2 (es)
AU (2) AU684496B2 (es)
BR (1) BR9305075A (es)
DE (1) DE4419264B4 (es)
ES (1) ES2091159B1 (es)
FR (1) FR2714065B1 (es)
GB (2) GB9410856D0 (es)
IT (1) IT1269879B (es)
NZ (2) NZ314432A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175226B1 (en) * 1999-03-12 2009-08-19 University of Massachusetts Lipoglycan compositions and methods of treating parasitic infections
WO2002094228A1 (en) * 2001-05-23 2002-11-28 David Follansbee Prevention and treatment of allergies by helminthic regulation of ige
BRPI0303266B8 (pt) * 2003-01-31 2021-05-25 Fundacao Oswaldo Cruz proteína recombinante sm14, composição imunogênica, e,kit de diagnóstico.
US20110158998A1 (en) * 2005-08-03 2011-06-30 The Council Of The Queensland Institute Of Medical Research Helminth antigen and immunotherapy
KR101245004B1 (ko) * 2010-10-14 2013-03-19 원광대학교산학협력단 주혈흡충증 진단에 유용한 합성 주혈흡충 특이항원 및 이를 포함하는 주혈흡충증의 검출을 위한 진단 키트
BR102021012953A2 (pt) 2021-06-29 2023-01-10 Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso
WO2026015966A1 (pt) * 2024-07-19 2026-01-22 Fabp Biotech Desenvolvimento Em Biotecnologia S/A Composição terapeutica para proteger animais caninos, felinos, ovinos ou ruminantes contra nematoide dirofilaria immitis e haemonchus contortus, uso da composição e método para prevenção de infecção causada por nematoides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396600A (en) * 1980-12-18 1983-08-02 Gus Gallucci Adult schistosome worm-derived antigenic substance and method of obtaining same
US4656033A (en) * 1985-06-05 1987-04-07 The United States Of America As Represented By The Department Of Health And Human Services Isolated, soluble immunogen against Schistosoma mansoni and a method of vaccination employing same
WO1990002563A1 (en) * 1988-09-07 1990-03-22 Medical Research Council Antigens of schistosoma mansoni
US5219566A (en) * 1988-09-30 1993-06-15 The Johns Hopkins University Immunoprophylactic polypeptides for schistosomiasis
US5051254A (en) * 1988-09-30 1991-09-24 The Johns Hopkins University Immunoprophylactic polypeptides for schistosomiasis
IL100783A0 (en) * 1992-01-28 1992-09-06 Yeda Res & Dev Vaccine against schistosomiasis
GB9209993D0 (en) * 1992-05-08 1992-06-24 Munn Edward A Vaccines
GB9322808D0 (en) * 1993-11-05 1993-12-22 Agricultural & Food Res Vaccines
DE19960225B4 (de) * 1999-12-14 2007-03-01 Max Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Kristallines, in der asymmetrischen Einheit mindestens eine an der Katalyse beteiligte (Sub)-Domaine eines humanen m-Calpains aufweisendes Polypeptid, Verfahren zur Identifizierung von Verbindungen unter dessen Verwendung, Verfahren zu dessen Kristallisation und Verfahren zur Darstellung einer 3-dimensionalen Struktur dieses Peptids

Also Published As

Publication number Publication date
IT1269879B (it) 1997-04-15
GB9425479D0 (en) 1995-02-15
AU6341794A (en) 1995-06-29
DE4419264B4 (de) 2010-06-10
ES2091159A1 (es) 1996-10-16
DE4419264A1 (de) 1995-06-22
GB2285626B (en) 1998-04-15
AU684496B2 (en) 1997-12-18
JP4087908B2 (ja) 2008-05-21
FR2714065A1 (fr) 1995-06-23
NZ314432A (en) 1997-11-24
AU1133195A (en) 1996-08-01
ITMI941134A1 (it) 1995-12-01
JPH07196689A (ja) 1995-08-01
NZ260649A (en) 1997-05-26
BR9305075A (pt) 1995-08-08
GB2285626A (en) 1995-07-19
GB9410856D0 (en) 1994-07-20
FR2714065B1 (fr) 1998-08-07
US5730984A (en) 1998-03-24
ITMI941134A0 (it) 1994-06-01

Similar Documents

Publication Publication Date Title
ES2074042T3 (es) Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores.
ES2144424T3 (es) Vacuna que comprende parte de la region constante de ige para el tratamiento de reacciones alergicas inducidas por ige.
CO4930292A1 (es) Proteinas cry 1c modificada para la expresion en plantas de 8-endotoxinas activas contra lepidopteros, composiciones que comprenden dichas proteinas y metodo para producirla
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
CO2022014871A2 (es) Polipéptidos variantes proteolíticamente estables de u1-agatoxina-ta1b para el control de plagas
DE69522216D1 (de) Zielzellen-bindende chimäre Peptide
DE69231946D1 (de) Protein-induzierende morphogenese
KR900700505A (ko) 폐포계면활성 단백질
ES2052791T3 (es) Nuevos peptidos señal capaces de funcionar en levaduras, y expresion secretora de proteinas heterologas que utilizan los mismos.
SE8801701D0 (sv) Production technology based on enzymic method
Pruett Jr Proteolytic cleavage of bovine IgG by hypodermin A, a serine protease of Hypoderma lineatum (Diptera: Oestridae)
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
ATE269904T1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
ATE252153T1 (de) Rekombinanter birnavirusimpfstoff
ES2060134T3 (es) Inhibidor de tejido de metaloproteasas (timp-2).
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
AR021466A1 (es) Nucleotidos y proteina antitrombina de la mosca de los cuernos
ES2080024B1 (es) Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos.
DK0546036T3 (da) Vacciner
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
ATE129744T1 (de) Rekombinantes c-terminal alpha amidatierungsenzym von menschlischem thyroidursprung.
ES2160521A1 (es) Proteina cd29 porcina, acido nucleico que codifica para dicha proteina, y sus aplicaciones.
Souisby How parasites tolerate their hosts

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19961016

Kind code of ref document: A1

Effective date: 19961016

EC2A Search report published

Date of ref document: 19961016

Kind code of ref document: A1

Effective date: 19961016

FD2A Announcement of lapse in spain

Effective date: 20141120